ALESSANDRI, Amedea Caterina
 Distribuzione geografica
Continente #
NA - Nord America 556
EU - Europa 297
AS - Asia 85
SA - Sud America 1
Totale 939
Nazione #
US - Stati Uniti d'America 556
UA - Ucraina 76
CN - Cina 66
FI - Finlandia 64
IT - Italia 53
IE - Irlanda 23
GB - Regno Unito 22
DE - Germania 18
BE - Belgio 14
SE - Svezia 13
SG - Singapore 9
RU - Federazione Russa 6
FR - Francia 5
KR - Corea 3
TR - Turchia 3
IR - Iran 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BR - Brasile 1
HK - Hong Kong 1
PL - Polonia 1
RO - Romania 1
Totale 939
Città #
Chandler 72
Ann Arbor 50
Ashburn 46
Fairfield 44
Jacksonville 42
Wilmington 33
Houston 31
Woodbridge 26
Des Moines 23
Dublin 23
Seattle 22
Medford 16
Nanjing 16
Brussels 14
New York 14
Cambridge 13
Princeton 11
Boardman 10
Tulsa 9
Dearborn 7
Nanchang 7
Beijing 6
Shenyang 6
Changsha 5
San Diego 5
Singapore 5
Tianjin 5
Cagliari 4
Milan 4
Palermo 4
Genoa 3
Izmir 3
Jinan 3
Kunming 3
Seongnam 3
Altamura 2
Chicago 2
Duncan 2
Haikou 2
Hebei 2
Lanzhou 2
Lawrence 2
Ningbo 2
Nutley 2
Rome 2
San Paolo di Civitate 2
Tappahannock 2
Tehran 2
Central District 1
Cutrofiano 1
Dubai 1
Frankfurt Am Main 1
Hangzhou 1
Hefei 1
Jiaxing 1
Kiev 1
Kilburn 1
Ludwigshafen am Rhein 1
Mountain View 1
New Bedfont 1
Philadelphia 1
San Mateo 1
São Paulo 1
Taiyuan 1
Taizhou 1
Verona 1
Totale 632
Nome #
Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis. 151
Reliability of the bright liver echo pattern in diagnosing steatosis in patients with cryptogenic and HCV-related hypertransaminasaemia. 151
Retreatment of interferon plus ribavirin unresponsive patients with chronic hepatitis C with peginterferon alfa 2a plus mycofenolatemofetile or peginterferon alfa 2 a plus ribavirin 88
Himpact of liver steatosis on the antiviral response in the hepatitis C virus –associated chronic hepatitis. 84
Studio sulla frequenza dei genotipi virali e loro risposta terapeutica su un gruppo di soggetti ex drug dipendents con epatite cronica HCV-correlata. 81
PREVALENZA ED INCIDENZA DELLE EPATITI CRONICHE IN DIFFERENTI POPOLAZIONI DELLA SICILIA OCCIDENTALE 75
The treatment of chronic hepatitis C: role of ICAM-1 and response to interferon 72
Safety and efficacy of peginterferon alpha 2a plus mycofenolatemofetile and peginterferon alpha 2a plus Ribavirin in unresponsive patients with chronic hepatitis C 71
safety and efficacy of peginterferon (PEG-IFN) alpha 2a plus mycofenolatemoftile and peginterfron alpha 2a plus ribavirin in unresponsive patients with chronic C hepatitis 66
L’esposizione professionale in ambiente sanitario: attuali dati sulla valutazione e prevenzione del rischio 62
Safety and efficacy of Peginterferon (PEG-IFN) alpha 2 a(40 Kda) plus mycofenolatemofetile (MMF) and Peginterferon alpha 2 a plus Ribavirin (RBV) in unresponsive patients with chronic C hepatitis (CHC). 54
Totale 955
Categoria #
all - tutte 2.935
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.935


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020203 29 3 14 10 20 24 29 8 23 8 22 13
2020/2021127 4 14 8 14 11 4 15 3 17 3 13 21
2021/2022103 2 29 2 11 1 0 5 6 10 14 5 18
2022/2023170 12 22 1 25 27 34 16 17 11 0 4 1
2023/202494 4 13 5 24 2 19 2 4 0 1 8 12
2024/20255 5 0 0 0 0 0 0 0 0 0 0 0
Totale 955